Abstract Submission

Abstracts can be submitted to any of the following topics:

  • Spondylarthropathies
  • Systemic Connective Tissue Diseases
  • Osteoarthritis
  • Osteoporosis
  • Paediatric Rheumatology

The abstract submission deadline is 12 October 2011.

PRESENTATION TYPES

Please bear in mind that the Scientific Organising Committee will review all submitted abstracts and decide as to the form of presentation (oral or poster) as well as the topic the abstract will be presented under.
 

ABSTRACT SUBMISSION / GENERAL INFORMATION

  • The abstract submission deadline expires on 12 October 2011.
  • Abstracts for the Excellence in Rheumatology can be submitted by e-mail or online only.
  • In order to submit an abstract, at least the presenting author has to be registered to the Conference.  In case the same author presents more than one abstract, for each additional abstract a different co-author must be registered to the Conference.
  • An author may present one (1) paper only. However, anyone listed as co-author may present another person’s paper, if the main author/presenter is not able to attend the Conference. 
  • The Scientific Organising Committee of the Conference will decide on the presentation type of each abstract, the thematic stream the abstract will be presented under as well as on the date and time of each presentation.
  • The author indicated as the contact person will be notified about the successful submission of the abstract within three (3) days of it being received. In the event that such notification is not received, please contact the Conference Organisers. 
  • Presenting authors will be informed about the status of their abstract (accepted / rejected), by 31 October 2011. 
  • All accepted abstracts will be included in the Book of Abstracts of Excellence in Rheumatology, which will be published as a supplement to the Rheumatology Journal published by Oxford University Press.  Abstracts from non-registered authors will not be accepted. 
  • The author acknowledges and agrees that both the supplement to the Rheumatology Journal referred to in paragraph 8, and/or each individual abstract submitted by them, may be published in hard copy form made available online to subscribers of the Rheumatology Journal, reproduced in whole or in part for marketing purposes by the Conference Organisers and/or reprinted by the publishers in whole or in part for resale in English or in any other language.
  • The deadline to withdraw an abstract is 23 October 2011.  After that date no withdrawals will be accepted and the approved abstracts will be published in the Book of Abstracts and/or posted on the Conference website.
  • The author hereby warrants that each abstract submitted by them has not previously been published in any form, including electronic, and is in no way a violation of existing copyright and that it contains nothing libellous, obscene, or misleading. The author hereby agrees to indemnify the Conference Organisers and/or the publisher on demand against any losses incurred as a result of a breach of this warranty.
  • Please read carefully and follow the instructions, as incomplete submissions will not be reviewed. 

ABSTRACT WITHDRAWAL

If you wish to withdraw an abstract, please contact the Conference Organisers by 23 October 2011, otherwise the abstracts, if accepted, will be published in the Excellence in Rheumatology Book of Abstracts and/ or will be posted on the Conference website.
 

ABSTRACT SUBMISSION GUIDELINES
Authors are kindly requested to adhere to the following submission guidelines:

A. Format

  • Language: English
  • Abstract text word limit: 300 words (names and affiliation details are not included)
  • Suggested font: Tahoma, size 10 cpi
  • Text justification : full 
  • Spacing between the title, the author(s) and the abstract text: Single
  • Line spacing of the text: Single
  • Abstract title typed in: UPPER CASE
  • Surname(s) of the author(s) typed in lower case preceded by the first name(s) written in full.(e.g. Maria Reynolds) .
  • The presenting author’s name must be written in bold.
  • The affiliation details of all authors [department, institution/hospital, city/town, state (if relevant) and country] should be typed under the names, preceded by the corresponding indices. The affiliations should NOT be mentioned in the abstract text
  • The abstract should be divided into the following categories, the titles being typed in lower case and in bold:
  • Background
  • Methods
  • Results
  • Conclusions
  • The text may include standard abbreviations, tables, diagrams and photographs, as long as they remain within the page margins and the total amount of words does not exceed the abovementioned limit (300 words).

Disclosure of interests’ conflict
Please insert one of the following statements at the end of your abstract in order to declare any conflicts of interest:
‘Disclosure statement: The authors have declared no conflicts of interest.’
‘Disclosure statement: A.B. (author’s name) received an honorarium from X (party provided honorarium). All other authors declared no conflicts of interest (please refer to the example overleaf)

The  responsibility  for  accuracy  rests  with  the  author

B. Submission

Via e-mail:
You may send the abstract to the e-mail address attaching:
a) the Registration& Abstract submission form duly completed
b) theabstract in Microsoft Office Word having followed the instructions given above.

Kindly note that only REGISTERED delegates can submit an abstract.  Please note that abstract submitted without registration number will not be accepted.

Via website:

Authors may submit their abstract online by clicking HERE and completing all required fields. Should you encounter any difficulties in submitting your abstract on-line please do not hesitate to contact the Conference Organiser at

You may submit your abstract by clicking on the Submit an Abstract online at http://excellence-in-rheumatology.org and completing all required fields. If you should experience any problems with the online submission, please do not hesitate to contact the Conference Organisers.
Abstracts submitted via fax or mail will NOT be accepted.
Please address any inquiries regarding abstract submission to the Conference Organisers:
C&C International Group of Companies
1A Pierias str, 14451, Athens, Greece
Tel: +30 210 6889130
Fax: +30 210 6844777 (attn. Registrations & Abstracts Dpt.)
E-mail (Registrations & Abstracts Dpt.) :

REVIEW PROCESS
All submissions will be reviewed by the Scientific Organising Committee and evaluated in terms of their appropriateness and their overall quality. While the review is intended to be constructive and educational, it will also assist in the selection of submissions for presentation.